Literature DB >> 34994953

Combination of electroconvulsive stimulation with ketamine or escitalopram protects the brain against inflammation and oxidative stress induced by maternal deprivation and is critical for associated behaviors in male and female rats.

Helena M Abelaira1, Thayse Rosa1, Airam B de Moura1, Natalia M Andrade1, Nicoly S Martinello1, Larissa R Maciel1, Maria Eduarda M Botelho1, Laura A Borba1, Beatriz C Chede1, Camila O Arent1, Larissa Joaquim2, Sandra Bonfante2, Lucinéia G Danielski2, Talita Tuon1, Fabricia Petronilho2, João Quevedo1,3,4,5, Gislaine Z Réus6.   

Abstract

This study aimed at evaluating the treatment effects with ketamine, electroconvulsive stimulation (ECS), escitalopram, alone or in combination in adult rats of both sexes, subjected to the animal model of maternal deprivation (MD). All groups were subjected to the forced swimming test (FST), splash and open field tests. The prefrontal cortex (PFC), hippocampus and serum were collected to analyze oxidative stress and inflammatory parameters. MD induced depressive-like behavior in the FST test in males and reduced grooming time in male and female rats. The treatments alone or combined reversed depressive and anhedonic behavior in females. In males, all treatments increased grooming time, except for ECS + escitalopram + ketamine. MD increased lipid peroxidation and protein carbonylation, nitrite/nitrate concentration and myeloperoxidase activity in the PFC and hippocampus of males and females. However, the treatment's response was sex dependent. Catalase activity decreased in the PFC of males and the PFC and hippocampus of females, and most treatments were not able to reverse it. MD increased the inflammation biomarkers levels in the PFC and hippocampus of males and females, and most treatments were able to reverse this increase. In all groups, a reduction in the interleukin-10 levels in the PFC and hippocampus of female and male rats was observed. Our study shows different responses between the sexes in the patterns evaluated and reinforces the use of the gender variable as a biological factor in MDD related to early stress and in the response of the therapeutic strategies used.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Electroconvulsive stimulation; Escitalopram; Inflammatory parameters; Ketamine; Major depressive disorder; Maternal deprivation; Oxidative stress

Mesh:

Substances:

Year:  2022        PMID: 34994953     DOI: 10.1007/s12035-021-02718-x

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  87 in total

1.  The preeminent role of early untoward experience on vulnerability to major psychiatric disorders: the nature-nurture controversy revisited and soon to be resolved.

Authors:  C B Nemeroff
Journal:  Mol Psychiatry       Date:  1999-03       Impact factor: 15.992

Review 2.  The Bidirectional Relationship of Depression and Inflammation: Double Trouble.

Authors:  Eléonore Beurel; Marisa Toups; Charles B Nemeroff
Journal:  Neuron       Date:  2020-06-17       Impact factor: 17.173

3.  Gender differences in depression in representative national samples: Meta-analyses of diagnoses and symptoms.

Authors:  Rachel H Salk; Janet S Hyde; Lyn Y Abramson
Journal:  Psychol Bull       Date:  2017-04-27       Impact factor: 17.737

4.  The economic burden of adults with major depressive disorder in the United States (2005 and 2010).

Authors:  Paul E Greenberg; Andree-Anne Fournier; Tammy Sisitsky; Crystal T Pike; Ronald C Kessler
Journal:  J Clin Psychiatry       Date:  2015-02       Impact factor: 4.384

Review 5.  Animal models of major depression and their clinical implications.

Authors:  Boldizsár Czéh; Eberhard Fuchs; Ove Wiborg; Mária Simon
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2015-04-17       Impact factor: 5.067

Review 6.  The organization of the stress system and its dysregulation in depressive illness.

Authors:  P W Gold
Journal:  Mol Psychiatry       Date:  2014-12-09       Impact factor: 15.992

Review 7.  Beyond the monoamine hypothesis: mechanisms, molecules and methods.

Authors:  I Hindmarch
Journal:  Eur Psychiatry       Date:  2002-07       Impact factor: 5.361

Review 8.  Global variation in the prevalence and incidence of major depressive disorder: a systematic review of the epidemiological literature.

Authors:  A J Ferrari; A J Somerville; A J Baxter; R Norman; S B Patten; T Vos; H A Whiteford
Journal:  Psychol Med       Date:  2012-07-25       Impact factor: 7.723

9.  Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma.

Authors:  Charles B Nemeroff; Christine M Heim; Michael E Thase; Daniel N Klein; A John Rush; Alan F Schatzberg; Philip T Ninan; James P McCullough; Paul M Weiss; David L Dunner; Barbara O Rothbaum; Susan Kornstein; Gabor Keitner; Martin B Keller
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-13       Impact factor: 11.205

10.  Early life stress and glutamate neurotransmission in major depressive disorder.

Authors:  Lynnette A Averill; Chadi G Abdallah; Lisa R Fenton; Madonna K Fasula; Lihong Jiang; Douglas L Rothman; Graeme F Mason; Gerard Sanacora
Journal:  Eur Neuropsychopharmacol       Date:  2020-05-15       Impact factor: 4.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.